Want to join the conversation?
$ARNA 2Q15 Call: Revised 2015 outlook: R&D expenses of $103-111MM vs. previous outlook of approx. $114-122MM; the revised outlook includes approx. $13MM in non-cash expenses and $1.4MM in development expenses reimbursed by Eisai, with such reimbursed expenses included in revenue. All other guidance previously given remains unchanged.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.